Crumly & Associates’s Johnson & Johnson JNJ Stock Holding History

Crumly & Associates’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$543K	Buy	+2,137	New	+$498K	0.1%	116

Other funds holding JNJ

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

AACR

ACR Alpine Capital Research St. Louis, Missouri $7.04B AUM 28% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Crumly & Associates's JNJ Position: Q2 2026 in Review

Crumly & Associates opened a new position in Johnson & Johnson (JNJ) in Q2 2026: 2,137 shares worth $543K. The stake represents 0.1% of the portfolio and ranks #116 among its holdings.

2,299 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

Crumly & Associates held 2,137 shares of Johnson & Johnson worth $543K as of Q2 2026.
Johnson & Johnson was a new Crumly & Associates position in Q2 2026.
Johnson & Johnson made up 0.1% of Crumly & Associates's portfolio in Q2 2026, its #116 holding.
2,299 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Crumly & Associates's 13F filing for Q2 2026, filed 8 Jul 2026.